Thermo Fisher to acquire Solventum's purification and filtration business for $4.1 billion
25/02/2025 13:38
Feb 25 (Reuters) - Contract drug manufacturer Thermo Fisher Scientific TMO.N said on Tuesday it will buy Solventum's SOLV.N purification and filtration business for about $4.1 billion in cash. The transaction is expected to be completed by the end of 2025. (Reporting by Christy Santhosh in Bengaluru; Editing by Shailesh Kuber) ((Christy.Santhosh@thomsonreuters.com;))
Recent news on Solventum
See all newsSolventum Corporation reports results for the quarter ended June 30 - Earnings Summary
Solventum to hive off healthcare software business, raises profit forecast
Solventum Q2 sales, adjusted EPS beat estimates; FY outlook lifted
Solventum Corp expected to post earnings of $1.91 a share - Earnings Preview
Solventum forecasts annual profit at higher end on wound care demand